ample amounts of magnesium (14.0 mmol per day), a
relation that may be important in understanding
metabolic mineral disorders that perturb calcium
balance. A similar phenomenon occurred in either
free-living sedentary or athletic premenopausal
women consuming self-selected typical Western diets
not different in analyzed calcium content; boron sup-
plementation (280 mmol per day) increased urinary
calcium loss. In a different study of older volunteers
fed a low-magnesium (4.73 mmmol 8330 kJ
1
), mar-
ginal copper (25.3 mmol 8330 kJ
1
) diet (men, and
women on or not on estrogen therapy), boron reple-
tion (300 mmol 8330 kJ
1
) after boron depletion
(21.3 mmol 8330 kJ
1
) significantly decreased calcito-
nin and significantly increased ionized calcium, but
not total calcium concentrations in serum in a manner
similar to that caused by estrogen therapy. In the
vitamin D-deficient rat model fed a low-boron diet,
supplemental dietary boron enhanced the apparent
absorption and retention of calcium and phosphorus
and increased femur magnesium concentrations.
0027 Boron and steroid metabolism There is clear evi-
dence that dietary boron affects steroid metabolism.
In particular, circulating concentrations of vitamin D
metabolites are sensitive to boron nutriture. The
number of vitamin D-deficient chicks with detectable
serum concentrations of 25-hydroxycholecalciferol
and the overall serum concentrations of 25-hydroxy-
cholecalciferol increased when boron-deprived chicks
(15 mmol B kg
1
) were supplemented with physio-
logical amounts of boron (280 mmol kg
1
). In the
same study, physiological supplements of boron
improved growth, feed efficiency, leg conditions,
and bone calcium, and serum ionized calcium in
broiler chicks fed low amounts of vitamin D, but
not in vitamin D-deprived or adequate chicks. These
findings indicate that dietary boron enhances the effi-
cacy of vitamin D but cannot substitute for the vita-
min. Further research is needed to determine whether
boron enhances vitamin D absorption or increases
cholecalciferol hydroxylase activity. In volunteers
(men, and women on or not on estrogen therapy),
boron supplementation after consumption of a low
boron diet increased serum 25-hydroxycholecalci-
ferol (62.4 + 7.5 vs. 44.9 + 2.5 mmol l
1
, mean +
SEM), an effect that may be especially important
during the winter months when those concentrations
normally range between 35 and 105 mmol l
1
.
0028 The circulating concentrations of 17b-estradiol also
respond to boron nutriture. Perimenopausal women
who excreted < 93 mmol of boron per day during the
placebo period exhibited increased serum concentra-
tions of estradiol after boron supplementation
(231 mmol of boron per day) of self-selected diets. In
a separate study, postmenopausal women on estrogen
therapy, but neither men nor postmenopausal women
not ingesting estrogen, also exhibited increased serum
concentrations of estradiol after boron supplementa-
tion (280 mmol of boron per day) of a low boron diet
(23 mmol of boron 8330 kJ
1
). However, plasma estra-
diol, but not testosterone, concentrations increased in
young male volunteers when their self-selected diets
were supplemented with ample amounts of boron
(10 mg per day).
0029Boron and enzyme regulation Boron influences the
activities of at least 26 enzymes examined (various
oxidoreductases, transferases, hydrolases, and iso-
merases), most often in an inhibitory manner, by bind-
ing to cofactors (e.g., NAD) or substrates, or by
unknown mechanisms. Reversible enzymatic inhib-
ition as an essential role for an element is unusual.
However, there is irrefutable evidence that boron
serves to inhibit or dampen several metabolic path-
ways in higher plants. A serious outcome of boron
deficiency in plants is starch accumulation, a condi-
tion thought to be caused by increased activity of
an enzyme in that pathway, starch phosphorylase.
Oxidoreductase enzymes that require pyridine (e.g.,
NAD
þ
or NADP) or flavin (e.g., FAD) nucleotides (EC
1.1.1, 1.1.3, 1.2.1, 1.3.5, 1.6.2) are competitively in-
hibited by borate or its derivatives as boron competes
for the NAD or flavin cofactor. The serine proteases
(EC 3.4.21) represent one critical sub-subclass of
hydrolases that have many essential regulatory roles
including the blood coagulation system (e.g., coagula-
tion Factor Xa). Boron reversibly inhibits the activity
of these enzymes by serving as a transition-state
analog. It is possible that boron acts as an unobtrusive
metabolic regulator by quenching the activity of some
enzymes and/or stabilizing reactive compounds to
limit the hyperactivity of several physiological systems
including the normal inflammatory response.
0030Boron and membrane function There are numerous
indications that boron is important for membrane
function. The esterification reaction that produces
boromonoesters (e.g., Figure 1 or 2) is easily revers-
ible, because these esters are completely hydrolyzed
when transferred into water. Therefore, it is reason-
able that boromonoesters in the hydrophobic envir-
onment of the lipid portion of the plasmalemma
should have a prolonged functionality, because the
absence of water in these environments shifts the
equilibrium to the right (eqn (2)).
BðOHÞ
3
þ 3ROH $ BðORÞ
3
þ 3H
2
O: ð2Þ
0031Heterocystous cyanobacteria may require boron
interactions with polyhydroxy components of the
572 BORON